Abiopharma

🔍 LeBlanc Dorian Paul (Executive)

Company: LEMAITRE VASCULAR INC (LMAT)

Report Date: 2025-09-04

Detailed Transactions and Holdings:

• Acquired 3 shares of Dividend Equivalent Rights (Derivative)
  Date: 2025-09-04 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8.46 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 3/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.